Market Research Logo

Diagnostics and Therapeutics for Lung Cancer: Global Markets

Diagnostics and Therapeutics for Lung Cancer: Global Markets

The global market for lung cancer grew to $21.9 billion in 2014 from $20.3 billion in 2013. The market is expected to grow at a five-year compound annual growth rate (CAGR) of 7.8% from 2014 to 2019, totaling $31.8 billion in 2019.

This report provides:

An overview of the global markets for lung cancer diagnostics and therapeutics.

Analyses of global market trends, with data from 2013, 2014, and projections of CAGRs through 2019.

Coverage of diagnostics such as histology/cytology, immunoassays, flow cytometery, rapid tests, molecular assays, tissue arrays, and circulating tumor cells.

In-depth analysis of biomarkers and how they are playing a role in lung cancer treatment.

Evaluation of the market's dynamics, specifically growth drivers, inhibitors, and opportunities.

A look at the competitive landscape through profiles of major players in the industry.


SCOPE OF THE REPORT

The report will analyze the lung cancer market as per diagnostics and therapeutics, and will also focus on the regulations and government supported programs impacting this market. Regionally, the focus of study will be the markets of North America, Europe, Asia-Pacific and Rest of the World (ROW).

This report includes various lung cancer diagnostics tests like histology/cytology, immunoassays, flow cytometry, rapid tests, molecular assays, tissue arrays, circulating tumor cells, pharmacodiagnostics, and molecular biomarkers, etc. Lung cancer therapeutics include chemotherapy, radiotherapy and surgery.

CHAPTER 1 INTRODUCTION
STUDY AND OBJECTIVES
TITLE DESCRIPTION
SCOPE OF THE REPORT
MARKET STRUCTURE
INTENDED AUDIENCE
RESEARCH METHODOLOGY
ANALYST'S CREDENTIALS
RELATED BCC RESEARCH REPORTS
BCC RESEARCH WEBSITE
DISCLAIMER
CHAPTER 2 EXECUTIVE SUMMARY
SCOPE OF LUNG CANCER
LUNG CANCER EPIDEMIOLOGY TRENDS
CURRENT DIAGNOSTICS AND THERAPEUTIC TREATMENTS OF LUNG CANCER
UNMET MARKET NEEDS
RESEARCH AND DEVELOPMENT (R&D) TRENDS
PIPELINE ANALYSIS
SUMMARY TABLE GLOBAL MARKET FOR LUNG CANCER, THROUGH 2019 ($ MILLIONS)
SUMMARY FIGURE GLOBAL MARKET FOR LUNG CANCER, 2013-2019 ($ MILLIONS)
CHAPTER 3 MARKET OVERVIEW
MARKET DEFINITION AND GLOBAL CANCER STATISTICS
CANCER DIAGNOSIS AND THERAPY MANAGEMENT
LUNG CANCER OVERVIEW AND STATISTICS
TYPES AND STAGES OF LUNG CANCER
NON-SMALL CELL LUNG CANCER (NSCLC)
Staging of NSCLC
SMALL CELL LUNG CANCER (SCLC)
Staging of SCLC
LUNG CANCER DIAGNOSIS AND THERAPY MANAGEMENT
MARKET ISSUES RELATED TO LUNG CANCER
HIGH DRUG COST
DRUG APPROVAL TIMELINE
DRUG RESISTANCE TO CANCER DRUGS
NOT ENOUGH PATIENTS IN CLINICAL TRIALS
FEDERAL EXPENDITURE
FIGURE 1 CANCER RESEARCH FUNDING, 2012 (DOLLARS PER LIFE COST)
FIGURE 2 FEDERAL FUNDING BY CANCER SITE, 2012 ($ MILLIONS)
FIGURE 3 FIVE-YEAR SURVIVAL RATES BY YEAR OF DIAGNOSIS (%)
RECESSION IN THE GLOBAL ECONOMY
INNOVATIONS IN METHODS OF DIAGNOSTICS AND THERAPEUTICS OF LUNG CANCER
LUNG CANCER MARKET ANALYSIS
NICE LIMITS THE USE OF ROCHE'S TARCEVA IN LUNG CANCER
ELI LILLY'S ALMITA LOSES PATENT WAR IN THE U.K.
FOCUS IS ON INCREASING DIFFERENTIATION BETWEEN THE THREE MAIN
NSCLC SUBTYPES
DRUG RESISTANCE TO THERAPIES
USE OF LOW-DOSE COMPUTED TOMOGRAPHY TO DETECT EARLY-STAGE LUNG CANCER
LUNG CANCER IN NON-SMOKERS
ASTRAZENECA'S MEDI4736, A VERY VIABLE DRUG FOR TREATING LUNG CANCER
LUNG CANCER MARKET STRATEGIES
MARKET SHARE OF KEY COMPANIES
FIGURE 4 MARKET SHARE OF KEY COMPANIES IN THE LUNG CANCER DIAGNOSTICS MARKET, 2014 (%)
GLOBAL MARKET FOR LUNG CANCER
TABLE 1 GLOBAL MARKET FOR LUNG CANCER BY TYPE, THROUGH 2019 ($ MILLIONS)
REGULATIONS
UNITED STATES
FIGURE 5 DRUG DISCOVERY AND DEVELOPMENT TIMELINE
CANADA
EUROPE
Nationalized Procedure
Mutual Recognition Procedure (MRP)
FIGURE 6 MUTUAL RECOGNITION PROCEDURE
Decentralized Procedure
FIGURE 7 DECENTRALIZED PROCEDURE
Centralized Procedure
INDIA
FIGURE 8 DRUG APPROVAL PROCESS IN INDIA
CHINA
Step 1: Application for Approval of Clinical Study (Clinical Trial or
Bio-Efficacy Study)
FIGURE 9 DRUG APPROVAL PROCESS IN CHINA
Step 2: Conducting Clinical Studies
FIGURE 10 PROCEDURE FOR CLINICAL STUDIES
Step 3: Final Approval for Drug Registration (After Clinical tudies)
FIGURE 11 FINAL APPROVAL FOR DRUG REGISTRATION
AFRICA
GOVERNMENT-SUPPORTED PROGRAMS
UNITED STATES
CANADA
EUROPE
INDIA
CHINA
AFRICA
COMMERCIALIZING NEXT-GENERATION CANCER TESTS
FIGURE 12 PENETRANCE BREAKDOWN OF NEXT-GENERATION SEQUENCING TESTS, 2013 (%)
CURRENT MARKET SCENARIO
REGULATORY REQUIREMENTS OF CANCER TESTS
REIMBURSEMENT CODING IN THE U.S.
ICD
GENE PATENTS AND TEST COMMERCIALIZATION
GENE PATENTING
FIGURE 13 BREAKDOWN OF GENETIC TESTS MARKET, 2013 (%)
MAJOR COMPANIES IN THE GENETICS SERVICES MARKET
IMPACT OF COMPANION TEST DEVELOPMENT
CONCLUSIONS AND STRATEGIC IMPLICATIONS
UNMET MARKET NEEDS
PIPELINE ANALYSIS
CHAPTER 4 LUNG CANCER DIAGNOSTICS MARKET
OVERVIEW
TABLE 2 GLOBAL MARKET FOR LUNG CANCER DIAGNOSTICS BY REGION, THROUGH 2019 ($ MILLIONS)
TABLE 3 GLOBAL MARKET FOR LUNG CANCER DIAGNOSTICS BY DIAGNOSTIC TEST, THROUGH 2019 ($ MILLIONS)
RESEARCH AND DEVELOPMENT
INNOVATIONS
TRENDS
REGULATIONS
COMPETITIVE LANDSCAPE
HISTOLOGY/CYTOLOGY
MARKET OVERVIEW
TABLE 4 GLOBAL MARKET FOR HISTOLOGY/CYTOLOGY BY REGION, THROUGH 2019 ($ MILLIONS)
COMPETITIVE LANDSCAPE
IMMUNOASSAYS
MARKET OVERVIEW
TABLE 5 GLOBAL MARKET FOR IMMUNOASSAYS BY REGION, THROUGH 2019 ($ MILLIONS)
COMPETITIVE LANDSCAPE
FLOW CYTOMETRY
MARKET OVERVIEW
TABLE 6 GLOBAL MARKET FOR FLOW CYTOMETRY BY REGION, THROUGH 2019 ($ MILLIONS)
COMPETITIVE LANDSCAPE
RAPID TESTS
MARKET OVERVIEW
TABLE 7 GLOBAL MARKET FOR RAPID TESTS BY REGION, THROUGH 2019 ($ MILLIONS)
COMPETITIVE LANDSCAPE
TABLE 8 LIST OF ALERE TEST PRODUCTS
MOLECULAR ASSAYS
MARKET OVERVIEW
TABLE 9 GLOBAL MARKET FOR MOLECULAR ASSAYS BY REGION, THROUGH 2019 ($ MILLIONS)
COMPETITIVE LANDSCAPE
TABLE 10 MYRIAD GENETICS TESTS
TISSUE ARRAYS
MARKET OVERVIEW
TABLE 11 GLOBAL MARKET FOR TISSUE ARRAYS BY REGION, THROUGH 2019 ($ MILLIONS)
COMPETITIVE LANDSCAPE
CIRCULATING TUMOR CELLS
MARKET OVERVIEW
TABLE 12 GLOBAL MARKET FOR CIRCULATING TUMOR CELLS BY REGION, THROUGH 2019 ($ MILLIONS)
COMPETITIVE LANDSCAPE
PHARMACODIAGNOSTICS, MOLECULAR
MARKET OVERVIEW
TABLE 13 GLOBAL MARKET FOR PHARMACODIAGNOSTICS, MOLECULAR BY REGION, THROUGH 2019 ($ MILLIONS)
COMPETITIVE LANDSCAPE
BIOMARKERS
MARKET OVERVIEW
TABLE 14 GLOBAL MARKET FOR BIOMARKERS BY REGION, THROUGH 2019 ($ MILLIONS)
COMPETITIVE LANDSCAPE
OTHER DIAGNOSTICS METHODS
DIGITAL PCR
Market Overview
Competitive Landscape
MASS SPECTROMETRY
Market Overview
Competitive Landscape
CHROMOSOME ANALYSIS
Market Overview
Competitive Landscape
NEXT-GENERATION SEQUENCING
Market Overview
Competitive Landscape
SAMPLE PREPARATION AND SYSTEM AUTOMATION
Market Overview
Competitive Landscape
ROLE OF IN VIVO CELLULAR AND MOLECULAR IMAGING
Market Overview
Competitive Landscape
CHAPTER 5 LUNG CANCER THERAPEUTICS MARKET
OVERVIEW
TABLE 15 GLOBAL MARKET FOR LUNG CANCER THERAPEUTICS BY REGION, THROUGH 2019 ($ MILLIONS)
TABLE 16 GLOBAL MARKET FOR LUNG CANCER THERAPEUTICS BY THERAPY TYPE, THROUGH 2019 ($ MILLIONS)
FIGURE 14 PREVALENCE OF LUNG CANCER BY TYPE, 2014 (%)
CHEMOTHERAPY
TABLE 17 GLOBAL MARKET FOR LUNG CANCER CHEMOTHERAPY BY REGION, THROUGH 2019 ($ MILLIONS)
DIFFERENT CONDITIONS IN CHEMOTHERAPY
FIGURE 15 BREAKDOWN OF LUNG CANCER DIAGNOSIS BY STAGE, 2004-2010 (%)
Chemotherapy after Surgery
Chemotherapy and Radiotherapy
Chemotherapy for Locally Advanced NSCLC or Cancer that Has Spread
CHEMOTHERAPY DRUGS
LOW-COST DESTINATION FOR CHEMOTHERAPY
TABLE 18 COST COMPARISON OF LUNG CANCER TREATMENTS IN THE U.S. AND INDIA ($)
INCREASING NUMBER OF LUNG CANCER PATIENTS IN THE U.S.
FIGURE 16 NUMBER OF CANCER CASES IN THE U.S. BY TYPE, 2014 (NUMBER OF CASES)
RADIOTHERAPY
TABLE 19 RADIATION THERAPY AND COST IN THE U.S., 2014 ($)
LINEAR ACCELERATOR RADIOTHERAPY MACHINES
PROTON THERAPY
PARTICLE THERAPY
FIGURE 17 ADVANTAGES AND DISADVANTAGES OF PARTICLE THERAPY RADIOTHERAPY MACHINES MUST NOT BE OUTDATED
RADIOTHERAPY TO INCREASE GLOBALLY
TABLE 20 GLOBAL MARKET FOR LUNG CANCER RADIOTHERAPY BY REGION, THROUGH 2019 ($ MILLIONS)
SURGERY
TABLE 21 GLOBAL MARKET FOR LUNG CANCER SURGERY BY REGION, THROUGH 2019 ($ MILLIONS)
TYPES OF SURGERY
FIGURE 18 GLOBAL MARKET SHARE FOR LUNG CANCER SURGERY BY TYPE, 2014 (%)
Thoracotomy
Robotic Surgery
Video-Assisted Thoracoscopic Surgery (VATS)
GEOGRAPHICAL ANALYSIS OF LUNG CANCER SURGERIES
The U.S.
Europe
The U.K
APAC
CHAPTER 6 COMPETITIVE LANDSCAPE
FIGURE 19 TOP STRATEGIC ACTIVITIES OF KEY COMPANIES, 2011-NOVEMBER 2014 (NUMBER)
TABLE 22 PRODUCT LAUNCHES AND APPROVALS IN THE LUNG CANCER MARKET, 2011 TO 2014
TABLE 23 AGREEMENTS AND EXPANSIONS IN LUNG CANCER MARKET, 2011 TO 2014
TABLE 24 MERGERS AND ACQUISITIONS AND OTHER STRATEGIES IN THE LUNG CANCER MARKET, 2011 TO 2014
CHAPTER 7 COMPANY PROFILES
ABBOTT LABORATORIES
TABLE 25 ABBOTT'S PRODUCT PORTFOLIO
TABLE 26 ABBOTT'S RECENT DEVELOPMENTS, 2011 TO NOVEMBER 2014
ACCURAY INC.
TABLE 27 ACCURAY'S PRODUCT PORTFOLIO
TABLE 28 ACCURAY'S RECENT DEVELOPMENTS, 2011 TO NOVEMBER 2014
AGILENT TECHNOLOGIES
TABLE 29 AGILENT'S PRODUCT PORTFOLIO
TABLE 30 AGILENT'S RECENT DEVELOPMENTS, 2011 TO NOVEMBER 2014
ARRAY BIOPHARMA
TABLE 31 ARRAY BIOPHARMA'S PRODUCT PORTFOLIO
TABLE 32 ARRAY BIOPHARMA'S RECENT DEVELOPMENTS, 2011 TO NOVEMBER 2014
ASURAGEN, INC.
TABLE 33 ASURAGEN'S PRODUCT PORTFOLIO
TABLE 34 ASURAGEN'S RECENT DEVELOPMENTS, 2011 TO NOVEMBER 2014
BECKMAN COULTER, INC.
TABLE 35 BECKMAN COULTERS PRODUCT PORTFOLIO
BECTON DICKINSON
TABLE 36 BECTON DICKINSON'S PRODUCT PORTFOLIO
TABLE 37 BECTON DICKINSON'S RECENT DEVELOPMENTS, 2011 TO NOVEMBER 2014
BIOMERIEUX
TABLE 38 BIOMERIEUX'S PRODUCT PORTFOLIO
TABLE 39 BIOMERIEUX'S RECENT DEVELOPMENTS, 2011 TO NOVEMBER 2014
BIO-RAD LABORATORIES
TABLE 40 BIO-RAD'S PRODUCT PORTFOLIO
TABLE 41 BIO-RAD'S RECENT DEVELOPMENTS, 2011 TO NOVEMBER 2014
BOEHRINGER INGELHEIM
TABLE 42 BOEHRINGER INGELHEIM'S PRODUCT PORTFOLIO
TABLE 43 BOEHRINGER INGELHEIM'S RECENT DEVELOPMENTS, 2011 TO NOVEMBER 2014
BRUKER CORPORATION
TABLE 44 BRUKER'S PRODUCT PORTFOLIO
TABLE 45 BRUKER'S RECENT DEVELOPMENTS, 2011 TO NOVEMBER 2014
COVIDIEN PLC
TABLE 46 COVIDIEN'S PRODUCT PORTFOLIO
TABLE 47 COVIDIEN'S RECENT DEVELOPMENTS, 2011 TO NOVEMBER 2014
DAKO DENMARK A/S
TABLE 48 DAKO'S PRODUCT PORTFOLIO
TABLE 49 DAKO'S RECENT DEVELOPMENTS RECENT DEVELOPMENTS, 2011 TO NOVEMBER 2014
DANAHER CORPORATION
TABLE 50 DANAHER'S PRODUCT PORTFOLIO
ELI LILLY
TABLE 51 ELI LILLY'S PRODUCT PORTFOLIO
TABLE 52 ELI LILLY'S RECENT DEVELOPMENTS, 2011 TO NOVEMBER 2014
ETHICON ENDO-SURGERY INC.
TABLE 53 ETHICON'S PRODUCT PORTFOLIO
TABLE 54 ETHICON'S RECENT DEVELOPMENTS, 2011 TO NOVEMBER 2014
HOLOGIC
TABLE 55 HOLOGIC'S PRODUCT PORTFOLIO
TABLE 56 HOLOGIC'S RECENT DEVELOPMENTS, 2011 TO NOVEMBER 2014
MERCK MILLIPORE
TABLE 57 MERCK MILLIPORE PRODUCT PORTFOLIO
TABLE 58 MERCK MILLIPORE RECENT DEVELOPMENTS, 2011 TO NOVEMBER 2014
OLYMPUS CORP.
TABLE 59 OLYMPUS' PRODUCT PORTFOLIO
PFIZER
TABLE 60 PFIZER'S PRODUCT PORTFOLIO
TABLE 61 PFIZER'S RECENT DEVELOPMENTS, 2011 TO NOVEMBER 2014
QIAGEN
TABLE 62 QIAGEN'S PRODUCT PORTFOLIO
TABLE 63 QIAGEN'S RECENT DEVELOPMENTS, 2011 TO NOVEMBER 2014
RAYBIOTECH
TABLE 64 RAYBIOTECH'S PRODUCT PORTFOLIO
TABLE 65 RAYBIOTECH'S RECENT DEVELOPMENTS RECENT DEVELOPMENTS, 2011 TO NOVEMBER 2014
ROCHE DIAGNOSTICS
TABLE 66 ROCHE DIAGNOSTICS' PRODUCT PORTFOLIO
TABLE 67 ROCHE DIAGNOSTICS' RECENT DEVELOPMENTS, 2011 TO NOVEMBER 2014
SIEMENS HEALTHCARE
TABLE 68 SIEMENS HEALTHCARE'S PRODUCT PORTFOLIO
TABLE 69 SIEMENS HEALTHCARE'S RECENT DEVELOPMENTS, 2011 TO NOVEMBER 2014
SIGMA ALDRICH
TABLE 70 SIGMA-ALDRICH'S PRODUCT PORTFOLIO
TABLE 71 SIGMA-ALDRICH'S RECENT DEVELOPMENTS RECENT DEVELOPMENTS, 2011 TO NOVEMBER 2014
THERMO FISHER SCIENTIFIC
TABLE 72 THERMO FISHER'S PRODUCT PORTFOLIO
TABLE 73 THERMO FISHER'S RECENT DEVELOPMENTS, 2011 TO NOVEMBER 2014
TRANSGENE SA
TABLE 74 TRANSGENE'S PRODUCT PORTFOLIO
TABLE 75 TRANSGENE'S RECENT DEVELOPMENTS, 2011 TO NOVEMBER 2014
TRINITY BIOTECH
TABLE 76 TRINITY'S PRODUCT PORTFOLIO
CHAPTER 8 PATENT ANALYSIS
FIGURE 20 NUMBER OF PATENTS BY REGION, 2011 TO NOVEMBER 2014 (NUMBER)
LIST OF PATENTS
UNITED STATES
TABLE 77 U.S. PATENTS, 2011 TO NOVEMBER 2014
EUROPE
TABLE 78 EUROPE'S PATENTS, 2011 TO NOVEMBER 2014
JAPAN
TABLE 79 JAPAN'S PATENTS, 2010 TO NOVEMBER 2014

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report